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Abstract
Introduction: A remarkable difference in care delivery pathways for Chronic Obstructive Pulmonary Disease (COPD) is the presence of hos-
pital-at-home for COPD exacerbations in England and its absence in the Netherlands. The objective of this paper is to explain this difference.
Methods: Descriptive COPD statistics and care delivery pathways on all care levels within the institutional context, followed by a com-
parison of care delivery pathways and an explanation of the difference with regard to hospital-at-home.
Results: The Netherlands and England show broad similarities in their care delivery pathways for COPD patients. A major difference is 
the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. Three possible explanations for 
this difference are presented: differences in the urgency for alternatives (higher urgency for alternative treatment models in England), the 
differences in funding (funding in England facilitated the development of hospital-at-home) and the differences in the substitution of tasks 
to nurses (substitution to nurses has taken place to a larger extent in England).
Discussion and Conclusion: The difference between the Netherlands and England regarding hospital-at-home for COPD exacerbations 
can be explained in three ways. Hospital-at-home has proved to be a safe alternative for hospital care for selected patients, and should be 
considered as a treatment option for COPD exacerbations in the Netherlands.
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Introduction
Chronic Obstructive Pulmonary Disease (COPD) is 
a chronic illness with pulmonary symptoms of dysp-
noea, cough and sputum production [1]. The disease 
is progressive over time and, as yet, not curable [1]. 
In Western countries the main risk factor for COPD is 
smoking [1]. The prevalence of COPD is increasing, 
mainly because of aging and the late effects of smok-
ing [2]. Although high prevalence is a global phenom-
enon, national and even regional differences can be 
observed [3, 4]. The burden of the disease is high for 
patients and society. Health care costs for COPD are 
rising while available resources are under increasing 
pressure. Hospital treatment of acute exacerbations of 
COPD is the main contributor to the high health care 
costs of COPD [5]. These developments have focused 
global attention on the disease and have led to new 
organisational interventions to manage the impact of 
the disease on patients and society.
Countries often respond in different ways to similar 
problems. International comparative research can 
yield insight into these similarities and differences, 
which in turn can serve to improve health and the func-
tioning of health services [6]. Both the Netherlands 
and England are facing an increasing prevalence of 
COPD. Reported prevalence in England varies from 
2.5% to 13.3%, depending on the study population 
and the definitions used [4, 7]. Prevalence is higher in 
socially deprived areas like the north of England [4]. It 
is estimated that 31% of patients are undiagnosed [8]. 
COPD prevalence in the Netherlands varies from 1.9% 
to 11.6% [3, 7]. The percentage undiagnosed patients 
is estimated at 19% [9].
A remarkable difference between England and the 
Netherlands in the organisation of care delivery to 
COPD patients concerns the development of a new 
form of care for COPD exacerbations in England— 
termed ‘hospital-at-home’. Hospital-at-home refers to 
treatment schemes that substitute (parts of) hospital 
admission with treatment at home. This arrangement is 
only available for patients for whom admission is con-
sidered necessary. Treatment at home is always for a 
limited time. In the Netherlands a similar development 
for patients who need to be admitted has not occurred.
The purpose of this article is to explain why hospital-
at-home is present in England and absent in the Neth-
erlands. To do so we will first briefly compare COPD 
care in England and the Netherlands. Next, we present 
three complementary explanations for the presence of 
hospital-at-home in England and its absence (so far) 
in the Netherlands. Lastly, we address the question 
of what the Netherlands can learn from England with 
regard to COPD care.
Methods
Our study is a descriptive comparison between COPD 
care in England and the Netherlands based on pre-
vious findings published in literature and databases. 
Statistics on COPD, health care use (i.e. number of 
hospitalisations and length of stay) and health care 
resources (i.e. number of respiratory physicians, num-
ber of general practitioners, number of available hos-
pital beds and financial resources) were obtained from 
both national and international databases to guarantee 
comparability. Furthermore, publications in national and 
international journals, communications from national 
professional associations and the results of the Con-
fronting COPD surveys in the Netherlands and the UK 
performed in 2003 [8, 9] were used. Hospital admissions 
include admissions with principal International Classi-
fications of Disease codes (ICD-10) J40-J44 [(chronic) 
bronchitis, emphysema, chronic obstructive pulmonary 
diseases] and J47 (bronchiectasis) [10]. These gener-
ally pertain to admissions for exacerbations. Statistics 
are presented as figure per 1000, 10,000 or 100,000 
population. For the description and comparison of 
care delivery pathways for COPD patients we studied 
national and international guidelines on COPD care as 
well as policy reports and documents from professional 
associations and organisations involved in COPD care 
in both countries.
In the UK the responsibility for health (care) is devolved 
to England, Scotland, Wales and Northern Ireland. This 
article focuses on England. However, if no other data 
are available, we use statistics representing the entire 
UK.
Results
Statistical overview of COPD in England
In 1998, the number of annual hospital episodes for 
COPD was 22 per 10,000 population, which increased 
to 25 per 10,000 population in 2008 [11]. The number 
of hospital admissions, standardised for the age distri-
bution of the population, was 360 per 10,000 popula-
tion in 2007 [11]. In 2003, approximately 14% of COPD 
patients was hospitalised [8]. The average length of 
hospital stay for COPD decreased between 1998 and 
2008 from 10.2 days to 8.0 days [11]. The Confronting 
COPD survey showed that the average annual direct 
health care costs of COPD in 2003 were £819 (€1270) 
per patient, half of which was spent on hospital admis-
sions [8]. About 53% of COPD patients have at least 
one comorbidity besides their COPD [8] and 55% of 
patients use some (inhaled) medication for their COPD 
[8].
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Statistical overview of COPD in the 
Netherlands
Between 1998 and 2002, the number of annual hos-
pital episodes for COPD dropped from 14.9 to 10.9 
admissions per 10,000 populations. Since then the 
number has remained stable [12]. In 2007, the num-
ber of hospital admissions, standardised for the age 
distribution of the population, was 128 per 10,000 
population [13]. In 2003, 9% of COPD patients was 
hospitalised [9]. The average length of hospital stay for 
COPD decreased from 15.2 days in 1998 to 10.4 days 
in 2007 [12]. The Confronting COPD survey indicated 
that in 2003, the average total direct costs per patient 
were €614 annually, of which 20% was spent on hos-
pital admissions [9]. One-third of COPD patients report 
to have at least one comorbidity and 73% of patients 
use some (inhaled) medications for COPD [9].
The organisation and funding of COPD 
care in England
In England, patients’ pathway in COPD care usually 
starts in primary care. General practitioners and prac-
tice nurses (although not always only dedicated to 
COPD) provide preventive care, diagnostics and treat-
ment and follow-up care in stable and acute phases 
(exacerbations) of the disease. The number of FTE 
(Full Time Equivalent) general practitioners in 2005 was 
55.7 per 100,000 population in the UK [14]. Eighty-six 
percent of patients stated that the general practitioner 
was the health professional they went to for the man-
agement of their COPD [8]. Only 14% received care 
from a respiratory physician [8].
COPD patients are offered several community services, 
for which most referrals are made by hospitals [15]. The 
community services are often led by specialist nurses 
[15]. In addition to general nursing services (medica-
tion support), practice nurses, community matrons or 
nurse specialists offer chronic disease management 
services (e.g. smoking cessation, education or long-
term oxygen services) or acute management services 
(e.g. home visits or outpatient clinics) [15–17]. Ser-
vices provided in the community are based secondary 
care (42%) or based in both secondary and primary 
care (41%) [15].
Patients can be referred to secondary care (hospi-
tals) for specialist examination according to the NICE 
guideline [18]. This guideline also includes instruc-
tions on which patients should be treated in primary 
and secondary care (outpatient care) and when hos-
pital admission should be considered. In addition to 
the inpatient treatment management of patients with 
acute exacerbations, hospitals also provide outpatient 
treatment and follow-up, diagnostic services and reha-
bilitation programmes. The available number of acute 
hospital beds in 2008 was 2.6 per 1000 population and 
2.2 in 1995 [19]. The main professionals involved in 
hospital care for COPD are respiratory physicians and 
(specialised) nurses. The number of respiratory phy-
sicians per 100,000 population was 1.7 in 2007 [20]. 
Physiotherapists are also involved in COPD care, 
mainly in hospitals and community or hospital-based 
rehabilitation programmes.
A special service available in 44% of British hospitals 
is hospital-at-home for patients with a COPD exacer-
bation who require hospital admission [21]. This type 
of care was developed in the UK in the mid-1990s. It 
differs in various respects from other types of care. 
As said, hospital-at-home is intended for patients who 
would otherwise be or remain hospitalised. This means 
that the patient’s condition requires hospital admission. 
Care at home is similar to the care provided in hospital. 
Hospital-at-home is a nurse-led facility. Care is deliv-
ered by specialised respiratory nurses, mostly based 
(but not necessarily employed) in secondary care, 
under clinical responsibility of the respiratory physician 
in secondary care. Nurses visit the patient for several 
days (mean is 11 days) to monitor recovery and initiate 
the patient’s own disease management [22]. Approxi-
mately 30% of hospital admissions for exacerbations is 
considered eligible for hospital-at-home [21]. Costs of 
hospital-at-home are estimated to be lower than usual 
hospital care. Skwarska et al. [23] found the mean total 
health care costs of hospital-at-home to be £877 per 
patient, whereas usual hospital care costs £1753. In 
a Spanish hospital-at-home scheme, a difference in 
mean costs was found of €810 per patient [24]. These 
results should be interpreted with some caution, how-
ever, as outcomes of the cost-analyses are influenced 
by the decision as to which costs are incorporated and 
the design of the scheme. A schematic overview of the 
English care delivery pathway is offered in Figure 1A.
Care is funded by Primary Care Trusts (PCTs) which 
control 80% of the (tax-financed) budget for health 
care [25]. PCTs are responsible for the assessment 
of the health care needs of local communities and the 
commissioning of services from providers in primary 
care, secondary care, private providers and from com-
munity services [25]. In addition, PCTs employ staff 
to deliver care directly. This staff may be stationed in 
primary care practices, secondary care (hospitals), or 
other care facilities. This arrangement makes it pos-
sible for PCTs to base (respiratory) nurses in second-
ary care to provide hospital-at-home care for COPD 
exacerbations, but also to commission this service 
from hospitals or primary care facilities. In practice, 
most hospital-at-home schemes are hospital-based 
services with nurses working on an outreach basis.
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100,000 population [personal communication]. Seventy-
five percent of medical specialists are organised in part-
nerships and are paid fee-for-service [30]. The remaining 
25% of respiratory physicians and all other hospital staff 
are salary-paid [30]. Physiotherapists involved in the treat-
ment of COPD patients work in hospitals, in rehabilitation 
programmes (secondary care), and in community (main-
tenance) reactivation programmes. Community nursing is 
a facility available for patients in their home setting. Com-
munity nurses are employed by home care organisations 
[31] and are involved in general services such as nurs-
ing, medication supervision, washing and dressing. Com-
munity nurses with a focus on COPD/lung diseases also 
provide chronic management services like smoking ces-
sation programmes and disease management [31]. Fig-
ure 1B shows an overview of the care delivery pathway 
for COPD patients in the Netherlands.
There are two separate insurance programmes for the 
funding of COPD care. Care provided by general prac-
titioners, hospitals and physiotherapists is covered by 
the mandatory basic health insurance scheme and by 
voluntary, complementary insurance schemes [31]. 
Health insurers are responsible for the purchasing and 
funding of this care [31]. Community nursing is covered 
by the exceptional medical expenses scheme [31].
Comparison of care delivery and 
explanation for hospital-at-home 
development in England
We find several common elements in the delivery of 
COPD care in England and the Netherlands. A first 
common element concerns the involvement of general 
The organisation and funding of COPD 
care in the Netherlands
Care pathways of COPD patients in the Netherlands 
usually start in primary care. General practitioners are 
involved in the prevention, diagnosis and treatment of 
the disease in chronic and acute phases, and follow-up 
care. In 2009, the Netherlands had 42.5 FTE general 
practitioners per 100,000 population [26]. Some aspects 
of the care (e.g. education, inhalation instruction) are 
delegated to practice nurses. In 2007, approximately 
62% of GP practices had practice nurses [27]; however, 
these nurses are often not dedicated to COPD only 
but also tend to patients with other chronic illnesses. 
Practice nurses mainly work in the general practice, but 
sometimes perform home visits as well (outreach).
Patients can be referred to secondary care facilities (hos-
pitals) and professionals, according to guidelines [28, 
29]. These guidelines describe which patients should be 
treated in primary or secondary care (outpatient care) 
and when hospital admission is indicated. The Confront-
ing COPD survey revealed that, in 55% of patients, the 
general practitioner is the primary physician that treats the 
COPD patient, whereas for 42% this was the respiratory 
physician at the hospital [9]. Apart from inpatient treatment 
in acute phases of the disease, hospitals provide diagnos-
tic facilities, specialist examination, prevention, treatment 
and follow-up (outpatient management) and outpa-
tient rehabilitation programmes. Respiratory nurses are 
involved in some of these activities. The number of acute 
hospital beds was 3.5 beds per 1000 population in 1995 
and 3 beds per 1000 population in 2008 [19]. The number 
of respiratory physicians in hospitals in 2011 was 2.7 per 
Primary care trust
A
Primary care Secondary care
- General practitioner
- Practice nurse
- Matrons - General services
- Chronic management services
- Acute exacerbation management
  services
- District nurses
- Community respiratory teams
- Physiotherapist
Community care
- Prevention
- Physician
- Inpatient treatment
Funding stream
Delivery
Referral and delivery
Referral
- Diagnostics
- Rehabilitation
Hospital at home
- Outpatient treatment/
  follow-up- Respiratory nurse
- Physiotherapist
- Diagnostics
- Treatment
- Follow-up
Figure 1A. Care pathway in England.
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practitioners, practice nurses or COPD nurse special-
ists in primary care. A second common element is the 
availability of inpatient and outpatient facilities in sec-
ondary care for diagnostics, prevention, treatment and 
follow-up care. However, England has a stronger focus 
on primary care, as illustrated by the higher number 
of FTE general practitioners per 100,000 populations 
in England (55.7 vs. 42.5) and the higher percentage 
of patients that is mainly treated by general practitio-
ners. Furthermore, the percentage of patients annually 
admitted to hospital and the standardised hospitalisa-
tion figure is higher in England than in the Netherlands 
[8, 9]. Further research is required to explore these 
and other differences, as this is beyond the scope of 
this article. Nonetheless, it seems that the demand 
for hospital beds for COPD exacerbations is higher in 
England. A third common element is that both coun-
tries use guidelines to describe when patients should 
be treated in primary or secondary care, when refer-
ral is necessary and when admission to the hospital is 
indicated. A fourth common element is the presence 
of chronic management services in the community, 
mainly delivered by nurses. However, in England more 
diverse services are available at the community level. 
A final common element is that in both countries tasks 
and responsibilities have been delegated to nurses to 
relieve some of the pressure on general practitioners 
and hospital doctors.
A significant difference in the care delivery pathways 
between England and the Netherlands concerns the 
acute management of exacerbations that require hospi-
tal admission. In England a service for COPD exacerba-
tions named hospital-at-home is available, whereas a 
comparable type of acute service to substitute hospital 
care when admission is indicated does not exist in the 
Netherlands. Why hasn’t any equivalent of hospital-at-
home schemes for selected patients with a COPD exac-
erbation been developed in the Netherlands so far? We 
suggest three explanations: the differences in urgency 
for alternatives, differences in funding, and differences 
in the substitution of tasks to nurses. These three expla-
nations do not exclude but complement each other.
Differences in funding
The first explanation concerns differences in the fund-
ing of COPD care. Whereas England has single-source 
funding, the Netherlands has a multiple-payer system 
with two separate insurance schemes. The single-
source funding in England has much facilitated the 
development of integrated care, like hospital-at-home 
and staff working across institutional boundaries and 
across different levels of care. In the Netherlands, the 
institutional split between the basic health insurance 
scheme on the one hand and the exceptional medical 
expenses scheme on the other is hampering the coor-
dinated delivery of COPD care and the development 
of intermediary services, such as hospital-at-home 
for acute COPD exacerbations. Hospital-at-home in 
England takes place under clinical responsibility of 
respiratory physicians in secondary care and works 
on an outreach basis from hospitals in the community, 
or it requires the involvement of community nurses. 
In the Netherlands, outreach activities in the commu-
nity by hospitals, under responsibility of the hospital, 
are not reimbursed by the health insurance scheme. 
At the same time, however, the exceptional medical 
expenses scheme forbids community care providers 
B
Primary care Secondary care
- General services
- (specialised) Community nurses
Exceptional medical expenses scheme
- Chronic management services
Community care
Funding stream
Basic and supplementary health insurance scheme Referral
- Inpatient treatment
- Prevention
- Diagnostics
- Outpatient rehabilitation
- Outpatient treatment/
  follow-up- Physician
- Respiratory nurse
- Physiotherapist
- Physiotherapist
- General practitioner
- Practice nurse
- Prevention
- Diagnostics
- Treatment
- Follow-up
- Reactivation
Figure 1B. Care pathway in the Netherlands.
 6
International Journal of Integrated Care – Volume 12, 18 May  – URN:NBN:NL:UI:10-1-112975 / ijic2012-40 – http://www.ijic.org/
to pay for care that takes place under responsibility of 
the hospital and that is covered by the hospital budget 
[31]. The example of hospital-at-home demonstrates 
how the co-existence of distinct financial flows in the 
Netherlands obstructs the integration of care. It is 
also important to note that, despite guidelines on who 
should be treated in primary and/or secondary care, 
there has always been some competition between 
hospitals, medical specialists and other providers (gen-
eral practitioners, home care organisations) regarding 
the treatment of COPD patients. Physicians receive 
reimbursement for every patient they treat. Almost all 
patients are listed in a general practice but it is finan-
cially rewarding for respiratory physicians and hospi-
tals to treat patients as well. Furthermore, the rivalry 
has been intensified by the fact that the payment of 
all providers has become more performance-related. 
Introduction of hospital-at-home in the Netherlands 
would have financial consequences for each provider. 
Fewer hospital admissions imply that hospitals would 
receive less funding as reimbursement is based on 
the number of registered admissions. This makes hos-
pitals less willing to participate in outreach treatment 
for COPD-patients.
A related difference between England and the Neth-
erlands is that the role of PCTs as funding organisa-
tion in England is stronger than the purchasing role 
of the health insurers in the Netherlands. PCTs have 
more leverage to initiate changes because they control 
almost the entire budget for health in their service area. 
In the Netherlands, health insurers have to compete 
with each other under the new Health Insurance Act, 
which may complicate the development of new forms 
of care (such as hospital-at-home). Furthermore, nearly 
all respiratory physicians in England are employed and 
paid by the NHS hospitals, whereas 75% of Dutch 
respiratory physicians are independent entrepreneurs. 
This results in a difference in power balance, interests 
and incentives for change. In hospitals where physi-
cians are salaried employees, the hospital has more 
power than when physicians operate in entrepreneur-
ial ventures.
Differences in urgency
The prevalence of COPD and the number of hospi-
talisations in England is higher than in the Nether-
lands, whereas England has fewer hospital beds 
than the Netherlands. Consequently, the pressure 
on the available beds is higher in England than in 
the Netherlands, especially during winters when the 
incidence of COPD exacerbations increases. These 
circumstances highlight how the urgency to develop 
alternatives for hospital admission and free hospital 
beds has been much higher in England than in the 
Netherlands.
Differences in the substitution of tasks to 
nurses
The third explanation concerns the role of nurses in 
health care provision. In hospital-at-home schemes, 
nurses supervise the treatment at home, which is a 
form of substitution. Both England and the Netherlands 
have delegated tasks from physicians to nurses, but in 
England the delegation started earlier than in the Neth-
erlands, and also on a larger scale [32, 33]. In England 
the incentive to delegate was strong because of the 
low number of hospital doctors per 100,000 popula-
tion and the government’s strategy to shift, as far as 
possible, health services from hospitals into the com-
munity (primary care and community care services) 
[34]. PCTs quickly recognised the cost-effectiveness 
of task substitution to nurses, and set up a large net-
work of (specialised) nurses to perform tasks, often in 
the community [33]. The delegation of tasks (or task 
substitution) began later in the Netherlands [32] on the 
argument that expanding the medical role of nurses 
could impact the specific relationship between patients 
and nurses and the clearly defined caring function of 
nursing [33]. Furthermore, in the Netherlands physi-
cian scarcity—which is the main driver for substitution 
—was less urgent than in England.
Lessons
In our comparison of the care delivery pathways of 
COPD patients in the Netherlands and England, we 
found not only common elements but also a significant 
difference: the presence of hospital-at-home for COPD 
exacerbations in England and its absence in the Neth-
erlands. We suggested three complementary expla-
nations for this remarkable difference. Table 1 shows 
that length of hospital stay is higher in the Netherlands 
than in England, while the Netherlands scores better 
with respect to the other variables. The third step in our 
analysis is to address the question whether the Neth-
erlands could learn from England in order to reduce 
the length of stay, in particular with regard to hospital-
at-home.
In England hospital-at-home has been shown to reduce 
the length of hospital stay: the average length of stay 
(which includes patients not eligible for hospital-at-
home) in hospitals with hospital-at-home is 8 days vs. 
9 days in hospitals without hospital-at-home [21]. In 
the Netherlands the average length of stay for COPD 
patients is still high with an average of 10.4 days. 
Although the reduction in length of stay reached by 
hospital-at-home in England is small, our suggestion 
is that the Netherlands can learn from this type of care. 
In England hospital-at-home for COPD exacerbations 
has been studied and described extensively. It has 
International Journal of Integrated Care – Volume 12, 18 May  – URN:NBN:NL:UI:10-1-112975 / ijic2012-40 – http://www.ijic.org/
This article is published in a peer reviewed section of the International Journal of Integrated Care 7
proved to be a safe alternative for traditional inpatient 
stay for selected patients, without negatively affecting 
patient outcomes [35]. In addition, patients accept this 
type of care and show great satisfaction [35].
In the Netherlands, the introduction of hospital-at-home 
for COPD exacerbations would perfectly fit the govern-
ment’s strategy to delegate more tasks from hospital 
specialists and general practitioners to nurses. How-
ever, the introduction of hospital-at-home in the Neth-
erlands has implications for the professionals involved. 
In order to realise a hospital-based outreach service, 
the available number of specialised nurses in hospi-
tals must be increased. However, considering how the 
funding system prohibits hospitals from funding out-
reach care, the option of using more readily available 
(non-specialised) community nurses for the home visits 
should be considered, as has already been suggested 
by Davison et al. [36]. This development would expand 
nurses’ activities with the supervision of patients that 
would otherwise be hospitalised. Another alternative 
could be to use practice nurses employed by general 
practitioners. This would bypass some of the barriers 
of the funding system since the funding of hospital 
care and primary care are part of the same segment. 
Furthermore, clinical responsibility for hospital patients 
that are being treated at home needs to be dealt with 
in the current funding system. It should be further 
explored whether general practitioners are willing to 
take responsibility and whether this would be feasible, 
or whether it would be possible, within the current sys-
tem, to retain clinical responsibility at the hospital.
The prospects of realising the introduction of hospital-
at-home in the Netherlands have improved with the 
government’s strategy of shifting some forms of com-
munity nursing from the exceptional medical expenses 
scheme to the basic health insurance scheme. This 
may help bring about a better integrated system of 
health services for COPD patients. Another promising 
development concerns the introduction of a bundled 
payment system for chronic care [37]. The essence of 
this model is to pay an annual budget for the treatment 
of patients with a chronic disease such as COPD. The 
bundle-payment covers a wide range of services for 
COPD patient contracted and delivered by care groups 
(which are often general practitioners) in primary care, 
as well as one consultation of a respiratory physician 
in secondary care. The care group can deliver the 
services directly, or can contract other providers (e.g. 
physiotherapists) to do so. Unfortunately, the funding 
of inpatient care and outpatient care provided by the 
Table 1. Statistics of COPD, related health care resources and health care costs with [reference]
COPD specific England The Netherlands
 COPD prevalence (per 100 population) 2.5–13.3 [4, 7] 1.9–11.6 [3, 7]
 Percentage of patients undiagnosed (2003) 31 [8] 19 [9]
 Percentage of patients reporting comorbidities 53 [8] 30 [9]
 Percentage of patients with COPD medication prescription 55 [8] 73 [9]
 Percentage of patients mainly treated by general practitioner 86 [8] 55 [9]
 Annual hospital episodes (per 10,000 population) (2008) 22 [11] 11.6 [12]
 Standardised number of hospital admissions (per 10,000 population)* (2007) 360 127
 Percentage of COPD patients annually admitted to the hospital (2003) 14 [8] 8 [9]
 Average length of hospital stay (days) 8† [11] 10.4‡ [12]
 Direct health care costs per patient (2003) €1270 (£819) [8] €614 [9]
 Percentage of COPD expenditure spent on hospital admissions 50 [8] 20 [9]
Non-COPD specific
 Number of hospital beds (per 1000 population) (2008) 2.6 [14] 3 [14]
 Number of hospital respiratory physicians (per 100,000 population) 1.7Δ [15] 2.6± [personal communication]
 Number of FTE general practitioners (per 100,000 population) 55.67‡ [16] 42.53β [17]
*Correction for countries’ age distribution [11, 13].
FTE, full time equivalent.
†:2008; ‡:2007; #:2000; Δ:2005; ±:2009; β:2011.
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hospital is not (yet) included in this budget. Community 
nursing is not included in this budget either. Ideally, the 
chain funding would cover all types of care in primary 
care, secondary care and community care.
Conclusion
This comparative study has demonstrated the differ-
ences and similarities in COPD care delivery path-
ways in the Netherlands and England. An important 
difference between both countries concerns the pres-
ence of hospital-at-home for COPD exacerbations in 
England. We have suggested three explanations for 
this difference. In England hospital-at-home for COPD 
exacerbations has proved to be a safe alternative for 
inpatient treatment, without adverse patient outcomes 
and with great patient satisfaction. We argue that the 
development of hospital-at-home COPD exacerbations 
should be seriously considered in the Netherlands to 
reduce length of hospital stay, which is significantly 
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